Time series analysis of the clinical laboratory test result on chemotherapy for gastric cancer

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 11, Issue 4, 2008, Pages 83-89

  Sotoishi, Noboru ^a,b   Katsube, Takao ^a   Ogawa, Kenji ^a   Yakou, Shigeru ^a   Takayama, Kozo ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; ERYTHROCYTE; HUMAN; MALE; PATHOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; STATISTICS; STOMACH TUMOR; TIME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; ERYTHROCYTES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STATISTICS AS TOPIC; STOMACH NEOPLASMS; TIME FACTORS;

EID: 65249119710     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3hs3p     Document Type: Article

References (15)

1. Yamada, Y., Hamaguchi, T., Goto, M., Muro, K., Matsumura, Y., Shimada, Y., Shirao, K. and Nagayama, S. Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil. Br J Cancer, 89: 816-820, 2003.
2. Taguchi, T., Inuyama, Y., Kanamaru, R., Hasegawa, K., Aiazawa, S., Niitani, H., et al. Phase I study of S-1. Jpn J Cancer Chemother, 24: 2253-2264, 1997.
3. Maehara, Y. S-1 in gastric cancer: a comprehensive review. Gastric Cancer, 6(Suppl 1): 2-8, 2003.
4. De Boor, C. A Practical Guide to Spline. Springer Verlag, New York, 2001.
5. Sandwell, D. T. Biharmonic spline interpolation of GEOS-3 and SEASAT altimeter data. Geophysical Research Letters, 14(2): 139-142, 1987.
6. Takayama, K. Multivariate spline interpolation as a novel method to optimize pharmaceutical formulations. Pharmazie, 59(5): 392-395, 2004.
7. Arai, H., Suzuki, T., Kaseda, C., Ohyama, K. and Takayama, K. Bootstrap re-sampling technique to evaluate the optimal formulation of theophylline tablets predicted by non-linear response surface method incorporating multivariate spline interpolation. Chem. Pharm. Bull., 55(4): 586-593, 2007.
8. Benson, P. Yang, Carina, W. Yang and Stephen, L. Ondra A novel mathematical model of the sagittal spine. Spine, 32(4): 466-470, 2007.
9. Hing, J., Perez-Ruixo, J.J., Stuyckens, K., Soto-Matos, A., Lopez-Lazaro, L. and Zannikos, P. Mechanism-based pharmacokinetic/ pharmacodynamic meta-analysis of Trabectedin (ET-743, Yondelis) induced neutropenia. Clin. Pharmacol. Ther., 83(1): 130-143, 2008.
10. van Kesteren, C., Zandvliet, A.S., Karlsson, M.O., Mathot, Ron, A.A., et al. Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam. Investigational New Drugs, 23: 225-234, 2005.
11. Sandstrom, M., Lindman, H., Nygren, P., Johansson, M., Bergh, J. and Karlsson, M.O. Population analysis of the pharmacokinetics and the haematological toxicity of the fluorouracil-epirubicin-cyclophosphamide regimen in breast cancer patients. Cancer Chemother Pharmacol, 58: 143-156, 2006.
12. Latz, J.E., Karlsson, M.O., Rusthoven, J.J., Ghosh, A. and Johnson, R.D. A semimechanisticphysiologic population pharmacokinetic/ pharmacodynamic model for neutropenia following pemetrexed therapy. Cancer Chemother. Pharmacol., 57: 412-426, 2006.
13. Tsukuda. M., Kida, A., Fujii, M., Kono, N., Yoshihara, T., Hasegawa, Y. and Sugita, M. Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Brit. J. Cancer, 93: 884-889, 2005.
14. Kimura, Y., Kikkawa, N., Iijima, AS., Kato, T., Naoi, Y., Hayashi, T., Tanigawa, T., Yamamoto, H. and Kurokawa, E. A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session. Jpn. J. Cancer Chemother., 29(8): 1403-1409, 2002.
15. Chollet, P., Schoffski, P., Weigang, K., Schellens, J.H.M., Cure, H., Pavlidis, N., Grunwald, V., De Boer, R., Wanders, J. and Fumoleau, P. Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG). European J. of Cancer, 39: 1264-1270, 2003.